Impressive Response to Tyrosine Kinase Inhibitors in a Patient with Respiratory Failure for EGFR-Mutated Metastatic Lung Cancer

Elena Bolzacchini, Graziella Pinotti(Medica (Italy)), Alessandro Tuzi(Ospedale di Circolo e Fondazione Macchi), Stefania Gobba(Aziende Socio Sanitarie Territoriale dei Sette Laghi)
Journal of Thoracic Oncology
November 21, 2017
10.1016/j.jtho.2017.08.023
Cited by 0

Related Papers

Adjuvant Exemestane with Ovarian Suppression in Premenopausal Breast Cancer
|New England Journal of Medicine|2014|751
Tailoring Adjuvant Endocrine Therapy for Premenopausal Breast Cancer
|New England Journal of Medicine|2018|684
High-dose cytarabine plus high-dose methotrexate versus high-dose methotrexate alone in patients with primary CNS lymphoma: a randomised phase 2 trial
|The Lancet|2009|665
Nongastric marginal zone B-cell lymphoma of mucosa-associated lymphoid tissue
|Blood|2003|490
Autografting Followed by Nonmyeloablative Immunosuppressive Chemotherapy and Allogeneic Peripheral-Blood Hematopoietic Stem-Cell Transplantation as Treatment of Resistant Hodgkin’s Disease and Non-Hodgkin’s Lymphoma
|Journal of Clinical Oncology|2000|228